Skip to main content

NATIXIS ADVISORS, LLC

Position in HALO — Halozyme Therapeutics, Inc.

CIK 1018331 Boston, MA

Position in HALO

as of Mar 31, 2026 · filed May 13, 2026
Position Value
$6,870,492
+$187,872 QoQ
Shares Held
106,305
+7.1% QoQ
Ownership
0.090%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2020
24 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in HALO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

NATIXIS ADVISORS, LLC holds $475,548,112 across 32 Biotechnology names. HALO ranks #7 (1.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
7 HALO
Halozyme Therapeutics, Inc.
This page
106,305 $6,870,492

All Filings in HALO

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $6,870,492 106,305
2025-12-31 $6,682,620 99,296
2025-09-30 $8,384,815 114,328
2025-06-30 $7,321,398 140,742
2025-03-31 $9,172,368 143,745
2024-12-31 $5,710,139 119,434
2024-09-30 $6,958,094 121,560
2024-06-30 $3,408,583 65,099
2024-03-31 $2,169,708 53,336
2023-12-31 $1,416,455 38,324
2023-09-30 $1,712,124 44,820
2023-06-30 $1,552,092 43,030
2023-03-31 $1,121,831 29,375
2022-12-31 $2,889,894 50,789
2022-09-30 $1,686,697 42,658
2022-06-30 $1,664,960 37,840
2022-03-31 $1,205,133 30,219
2021-12-31 $1,057,161 26,291
2021-09-30 $1,217,145 29,920
2021-06-30 $1,529,999 33,693
2021-03-31 $1,321,739 31,704
2020-12-31 $999,072 23,392
2020-09-30 $1,374,890 52,317
2020-06-30 $1,399,133 52,187